Genopliv ApS: Financial statements 2024
CVR: 43711172
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Genopliv ApS (CVR 43711172) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,214,424 and a net result of DKK 170,895 compared with DKK 491,818 the year before. That is a decrease of 6.7% compared with the year before. Equity in the 2024 report amounted to DKK 662,564. The solvency ratio was 49.4%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,214,424
- Profit/Loss
- DKK 170,895
- Equity
- DKK 662,564
- Total Assets
- DKK 1,341,496
- Employees
- 1
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Genopliv ApS has published its annual report for 2023. Gross profit came to DKK 1,301,478, and the net result was DKK 491,818.
About Genopliv ApS
Genopliv ApS is a Danish company of the type Anpartsselskab based in Holbæk, founded in 2022. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Kim Janos Pedersen. The company is owned by Kim Janos Pedersen. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 1,031,847 and a net result of DKK 117,485 compared with DKK 170,895 the year before. Equity in the 2025 report amounted to DKK 725,199.